Cost Analysis of FreeStyle Libre(R) 2 System in Type 2 Diabetes Mellitus Population
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Oyaguez, I
- Gomez-Peralta, F
- Artola, S
- Carrasco, FJ
- Carretero-Gomez, J
- Garcia-Soidan, J
- Gomez-Huelgas, R
- Perez, A
Grupos
Abstract
Introduction FreeStyle Libre(R) 2 system is a sensor-based flash-monitoring system that measures interstitial fluid glucose. The study aimed to compare cost of FreeStyle Libre 2 system and self-monitoring of blood glucose (SMBG) in the type 2 diabetes mellitus (T2DM) population from the Spanish Health System perspective. Methods On the basis of data collected from a literature review, the cost of glucose monitoring was modelled for patients with T2DM on a basal-bolus insulin regimen. The cost estimate included annual consumption for glucose monitoring (strips, lancets and sensors) and severe hypoglycaemic events (SHE) management. A published rate of SHE (2.5 episodes/patient-year) was considered. A reduction of SHE (- 48.8%) associated with FreeStyle Libre 2 system, derived from the REPLACE trial, was applied. Hospital attendance for 20.5% of SHEs (with subsequent hospitalization in 16.0%) was applied. Consumption of strips and lancets was set at 6/day for SMBG (derived from national monitoring recommendations), and 0.2/day for FreeStyle Libre 2 system users, with 26 FreeStyle Libre 2 sensors/year. Unitary costs (euro, year 2020 excluding VAT) were derived from literature (euro0.28/strip; euro0.09/lancet; euro3.09/daily FM sensor; euro3804/hospitalized SHE; euro1794/hospital-attended non-admitted SHE; euro389/community-attended SHE). Results Costs were euro2700 and euro2120/year/patient using SMBG or FreeStyle Libre 2 system, respectively. For 1000 patients with T2DM using basal-bolus insulin, 1220 SHEs/year (with 48 hospitalizations) could be prevented and FreeSytle Libre 2 system could generate cost savings of up to euro580,953/year versus SMBG (- 21.5%). Conclusion FreeStyle Libre 2 system is a potential cost-saving strategy in patients with T2DM in Spain on a basal-bolus insulin regimen.
Datos de la publicación
- ISSN/ISSNe:
- 1869-6953, 1869-6961
- Tipo:
- Article
- Páginas:
- 2329-2342
- PubMed:
- 33948909
- Factor de Impacto:
- 0,902 SCImago ℠
- Cuartil:
- Q2 SCImago ℠
Diabetes Therapy SPRINGER HEIDELBERG
Citas Recibidas en Web of Science: 15
Documentos
- No hay documentos
Filiaciones
Keywords
- Cost; Diabetes; Flash; FreeStyle Libre; Glucose monitoring
Cita
Oyaguez I,Gomez F,Artola S,Carrasco FJ,Carretero J,Garcia J,Gomez R,MERINO JF,Perez A. Cost Analysis of FreeStyle Libre(R) 2 System in Type 2 Diabetes Mellitus Population. Diabetes Ther. 2021. 12. (9):p. 2329-2342. IF:3,605. (3).
Portal de investigación